Nereus Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Nereus Pharmaceuticals Ownership

Who owns Nereus Pharmaceuticals?

Nereus Pharmaceuticals is owned by Triphase Accelerator. It was acquired on January 2, 2012.

Was Nereus Pharmaceuticals formerly PE-backed?

Yes. Nereus Pharmaceuticals was formerly owned by 1 private investor.

Nereus Pharmaceuticals Business Overview

Where is Nereus Pharmaceuticals headquartered?

Nereus Pharmaceuticals is headquartered in San Diego, California.

What sector is Nereus Pharmaceuticals in?

Nereus Pharmaceuticals is a life science company.

When was Nereus Pharmaceuticals founded?

Nereus Pharmaceuticals was founded in 1998.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Nereus Pharmaceuticals, Inc.

10480 Wateridge Circle,
San Diego, California 92121
United States,
www.nereuspharm.com

Nereus Pharmaceuticals is a pioneer in the use of marine microbial sources for the discovery and follow-on development of new therapeutics for cancer and inflammatory and infectious diseases.


 Subscribe to unlock this and 206,758
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.